MyFinsight
Home
Blog
About
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$46,590K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation
Depreciation
Accrued and other current liabil...
Others
Negative Cash Flow Breakdown
Net loss
Operating lease liability
Purchase of property and equipme...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-65,643
-58,158
-56,736
-61,457
Depreciation
4,112
4,109
4,544
4,587
Stock-based compensation
11,608
12,155
13,285
14,046
Loss on disposal of long-lived assets
0
8
-
0
Non-cash lease impairment expense
0
0
0
0
Net accretion of discount on marketable securities
-
-
0
-
Settlement of derivative contracts
-
-
0
0
Amortization of operating lease right-of-use asset
2,076
2,231
1,971
1,952
Adjustment to reconcile net income to cash provided by (used in) operating activity, other item
-
-
20
-
Prepaid expenses and other current assets
-340
975
1,063
-64
Other assets
-15
8
-6
15
Accounts payable
982
-733
1,626
5,315
Accrued and other current liabilities
3,508
4,558
-2
5,639
Operating lease liability
-3,236
-3,188
-3,021
-3,011
Long-term deposit
0
0
0
0
Net cash used in operating activities
-46,238
-40,009
-39,378
-32,880
Purchase of property and equipment
352
942
43
60
Deposits on property and equipment
-
-
0
0
Purchase of marketable securities
-
-
0
-
Maturities of marketable securities
-
-
0
-
Settlement of derivative contracts
-
-
0
0
Net cash used in investing activities
-352
-942
-43
-60
Proceeds from public offering, net of underwriting discount
-
-
172,960
-
Payment of public offering costs
0
303
-
-
Proceeds from stock option exercises
2,857
922
4,187
813
Proceeds from issuance of common stock pursuant to espp
106
-
98
0
Principal payments of tenant improvement allowance payable
-
-
0
-
Net cash provided by financing activities
2,963
619
177,245
813
Net decrease in cash, cash equivalents and restricted cash
-43,627
-40,332
137,824
-32,127
Cash, cash equivalents and restricted cash, at beginning of period
175,714
216,046
78,222
174,258
Cash, cash equivalents and restricted cash, at end of period
132,087
-
-
-
Cash and cash equivalents
125,903
-
-
-
Restricted cash
6,184
-
-
-
Total cash, cash equivalents and restricted cash in consolidated balance sheets
132,087
175,714
216,046
78,222
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from stock
option exercises
$2,857K
(1663.58%↑ Y/Y)
Proceeds from issuance of
common stock pursuant...
$106K
(29.27%↑ Y/Y)
Net cash provided by
financing activities
$2,963K
(1114.34%↑ Y/Y)
Net decrease in
cash, cash...
-$43,627K
(31.74%↑ Y/Y)
Canceled cashflow
$2,963K
Stock-based compensation
$11,608K
(-63.19%↓ Y/Y)
Depreciation
$4,112K
(-55.29%↓ Y/Y)
Accrued and other
current liabilities
$3,508K
(-3.52%↓ Y/Y)
Amortization of operating
lease right-of-use...
$2,076K
(-48.98%↓ Y/Y)
Accounts payable
$982K
(-13.02%↓ Y/Y)
Prepaid expenses and
other current assets
-$340K
(-214.81%↓ Y/Y)
Other assets
-$15K
(77.94%↑ Y/Y)
Net cash used in
operating activities
-$46,238K
(27.47%↑ Y/Y)
Canceled cashflow
$22,641K
Net cash used in
investing activities
-$352K
(12.66%↑ Y/Y)
Net loss
-$65,643K
(41.27%↑ Y/Y)
Operating lease liability
-$3,236K
(36.96%↑ Y/Y)
Purchase of property and
equipment
$352K
(-12.66%↓ Y/Y)
Buy us a coffee